 NEW YORK, Nov. 23, 2022 GLOBE NEWSWIRE -- Eyenovia, Inc. Nasdaq: EYEN, a pre-commercial ophthalmic technology company developing the Optejet delivery system for use both in combination with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced management will present at the BTIG Ophthalmology Day taking place virtually on November 29, 2022. Presentation details are below: 